can semaglutide increase liver enzymes Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Semaglutide Showing Promise in Treating

It is essential to view these dietary and lifestyle changes not as a temporary "diet" undertaken solely while on medication, but as the foundation for long-term health and well-being

Wilkinson, L

3) Results of the study found that subcutaneous injection of IGF-1 DES at the onset of diabetes can act as a protective measure against predegenerative biochemical abnormalities

Ethics approval and consent to participate N/A

Some small studies have shown promising results in the type 1 diabetes population, especially in those who are overweight and have insulin resistance

These cardiometabolic improvements matter because excess weight drives many of these risk factors